Timothy So
Physician Assistant · Long Beach, CANPI 1811901960
Payments from drug & device makers
Across 333 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$986
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$840
- Amgen$615
- Bayer$518
- Novo Nordisk$423
- Alkermes, Inc.$371
- plus $3K from 21 others
What the payments were for
- Food & beverage$6,276100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 54 | $986 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $840 |
| Amgen | 35 | $615 |
| Bayer | 25 | $518 |
| Novo Nordisk | 33 | $423 |
| Alkermes, Inc. | 18 | $371 |
| Sunovion Pharmaceuticals Inc. | 21 | $317 |
| AbbVie | 19 | $316 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $195 |
| Neurocrine Biosciences, Inc. | 7 | $177 |
| Johnson & Johnson | 6 | $176 |
| Otsuka America Pharmaceutical, Inc. | 7 | $158 |
| Lundbeck LLC | 7 | $152 |
| Novartis | 6 | $148 |
| Teva Pharmaceuticals USA, Inc. | 8 | $148 |
| AstraZeneca | 9 | $148 |
| Lilly USA, LLC | 5 | $107 |
| GSK | 5 | $100 |
| Gilead | 4 | $97 |
| Almatica Pharma LLC | 5 | $80 |
| Amarin Pharma, Inc. | 4 | $73 |
| Exact Sciences | 2 | $37 |
| Pfizer | 1 | $27 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Cipher Pharmaceuticals US LLC | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Merck | 1 | $12 |
How this compares
$6,276 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 257 | $155,597 |
| JardianceEmpagliflozin | 228 | $146,798 |
| FarxigaDapagliflozin Propanediol | 164 | $90,493 |
| RybelsusSemaglutide | 80 | $76,952 |
| KerendiaFinerenone | 114 | $73,157 |
| Diclofenac Sodium | 81 | $62,050 |
| VascepaIcosapent Ethyl | 127 | $36,319 |
| EliquisApixaban | 24 | $21,259 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $19,770 |
| TradjentaLinagliptin | 27 | $16,122 |
| VemlidyTenofovir Alafenamide | 11 | $15,069 |
| LinzessLinaclotide | 25 | $14,023 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 31 | $13,722 |
| OzempicSemaglutide | 14 | $12,578 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 277 | $11,701 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $14 | $172,058275 claims |
| MerckJanuvia, Janumet | $12 | $164,887274 claims |
| AstraZenecaFarxiga | $148 | $90,493164 claims |
| Novo NordiskRybelsus, Ozempic | $423 | $89,53094 claims |
| BayerKerendia | $518 | $73,157114 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Arexvy, Shingrix | $100 | $48,986125 claims |
| PfizerEliquis, Abrysvo | $27 | $27,92748 claims |
| GileadVemlidy | $97 | $15,06911 claims |
| AbbVieLinzess | $316 | $14,02325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Long Beach
- Amanda NelsonLong Beach$45K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.